Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1993 May;217(5):502–511. doi: 10.1097/00000658-199305010-00010

Development of a hybrid bioartificial liver.

J Rozga 1, M D Holzman 1, M S Ro 1, D W Griffin 1, D F Neuzil 1, T Giorgio 1, A D Moscioni 1, A A Demetriou 1
PMCID: PMC1242831  PMID: 8489313

Abstract

OBJECTIVE: The authors developed an extracorporeal liver support system and tested its efficacy in experimental animals with liver failure. The first clinical use of this system to treat a patient with liver failure is reported. SUMMARY BACKGROUND DATA: Multiple attempts have been made, ranging from plasma exchange to use of charcoal columns, to develop liver support systems for treating patients with acute severe liver failure. None of these systems has achieved wide clinical use. There is a need for providing liver support as a "bridge" to transplantation and for treating patients with potentially reversible liver dysfunction. METHODS: A hybrid liver support system has been developed consisting of plasma perfusion through a charcoal column and a porous hollow fiber module inoculated with 5 x 10(9) matrix-attached hepatocytes. The system was tested in dogs with ischemic liver failure (n = 7) who underwent plasmapheresis; a control group (n = 6) underwent charcoal perfusion alone. A patient with liver failure was treated with this hybrid system. RESULTS: After 6 hours of hybrid liver support treatment, animals had significantly decreased serum ammonia and lactate levels, increased glucose level, normal prothrombin time, and increased systolic blood pressure compared with controls treated with charcoal perfusion alone. Use of the system to treat a patient was well tolerated with evidence of clinical improvement. CONCLUSIONS: Plasma perfusion through a system consisting of a charcoal column and matrix-attached porcine hepatocytes had significant beneficial effects in animals with liver failure and was well tolerated by a patient with liver failure.

Full text

PDF
502

Images in this article

505Figure 2.
on p.505

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abouna G. M., Cook J. S., Fisher L. M., Still W. J., Costa G., Hume D. M. Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions. Surgery. 1972 Apr;71(4):537–546. [PubMed] [Google Scholar]
  2. Arnaout W. S., Moscioni A. D., Barbour R. L., Demetriou A. A. Development of bioartificial liver: bilirubin conjugation in Gunn rats. J Surg Res. 1990 Apr;48(4):379–382. doi: 10.1016/0022-4804(90)90079-h. [DOI] [PubMed] [Google Scholar]
  3. Berk P. D., Goldberg J. D. Charcoal hemoperfusion. Plus ça change, plus c'est la même chose. Gastroenterology. 1988 May;94(5 Pt 1):1228–1230. [PubMed] [Google Scholar]
  4. Bihari D., Hughes R. D., Gimson A. E., Langley P. G., Ede R. J., Eder G., Williams R. Effects of serial resin hemoperfusion in fulminant hepatic failure. Int J Artif Organs. 1983 Nov;6(6):299–302. [PubMed] [Google Scholar]
  5. Burnell J. M., Runge C., Saunders F. C., Thomas E. D., Volwiler W. Acute hepatic failure treated by cross circulation. Arch Intern Med. 1973 Oct;132(4):493–498. [PubMed] [Google Scholar]
  6. Chang T. M. Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review. Semin Liver Dis. 1986 May;6(2):148–158. doi: 10.1055/s-2008-1040598. [DOI] [PubMed] [Google Scholar]
  7. Cooper G. N., Jr, Karlson K. E., Clowes G. H., Martin H., Randall H. T. Total blood washout and exchange. A valuable tool in acute hepatic coma and Reye's syndrome. Am J Surg. 1977 Apr;133(4):522–530. doi: 10.1016/0002-9610(77)90142-8. [DOI] [PubMed] [Google Scholar]
  8. Demetriou A. A., Whiting J. F., Feldman D., Levenson S. M., Chowdhury N. R., Moscioni A. D., Kram M., Chowdhury J. R. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science. 1986 Sep 12;233(4769):1190–1192. doi: 10.1126/science.2426782. [DOI] [PubMed] [Google Scholar]
  9. Denis J., Opolon P., Nusinovici V., Granger A., Darnis F. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut. 1978 Sep;19(9):787–793. doi: 10.1136/gut.19.9.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gimson A. E., Braude S., Mellon P. J., Canalese J., Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet. 1982 Sep 25;2(8300):681–683. doi: 10.1016/s0140-6736(82)90711-5. [DOI] [PubMed] [Google Scholar]
  11. Gimson A. E., Braude S., Mellon P. J., Canalese J., Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet. 1982 Sep 25;2(8300):681–683. doi: 10.1016/s0140-6736(82)90711-5. [DOI] [PubMed] [Google Scholar]
  12. Gove C. D., Hughes R. D., Williams R. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure. Br J Exp Pathol. 1982 Oct;63(5):547–553. [PMC free article] [PubMed] [Google Scholar]
  13. Haas T., Holloway C. J., Osterthun V., Trautschold I. Hepatotoxic effects of sera from patients with fulminant hepatitis B on isolated rat hepatocytes in culture. J Clin Chem Clin Biochem. 1981 May;19(5):283–286. doi: 10.1515/cclm.1981.19.5.283. [DOI] [PubMed] [Google Scholar]
  14. Horák J., Horký J., Rábl M. Haemoperfusion through activated charcoal in dogs with fulminant liver failure. Digestion. 1980;20(1):22–30. doi: 10.1159/000198410. [DOI] [PubMed] [Google Scholar]
  15. Leffert H. L., Koch K. S., Moran T., Rubalcava B. Hormonal control of rat liver regeneration. Gastroenterology. 1979 Jun;76(6):1470–1482. [PubMed] [Google Scholar]
  16. Matsumura K. N., Guevara G. R., Huston H., Hamilton W. L., Rikimaru M., Yamasaki G., Matsumura M. S. Hybrid bioartificial liver in hepatic failure: preliminary clinical report. Surgery. 1987 Jan;101(1):99–103. [PubMed] [Google Scholar]
  17. O'Grady J. G., Gimson A. E., O'Brien C. J., Pucknell A., Hughes R. D., Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology. 1988 May;94(5 Pt 1):1186–1192. doi: 10.1016/0016-5085(88)90011-x. [DOI] [PubMed] [Google Scholar]
  18. Olumide F., Eliashiv A., Kralios N., Norton L., Eiseman B. Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer. Surgery. 1977 Nov;82(5):599–606. [PubMed] [Google Scholar]
  19. Pappas S. C. Fulminant hepatic failure and the need for artificial liver support. Mayo Clin Proc. 1988 Feb;63(2):198–200. doi: 10.1016/s0025-6196(12)64953-2. [DOI] [PubMed] [Google Scholar]
  20. Parbhoo S. P., James I. M., Ajdukiewicz A., Xanalatos C., Kennedy J., Chalstrey L. J., Brock P. J., Sayer P., Sherlock S. Extracorporeal pig-liver perfusoon in treatment of hepatic coma due to fulminant hepatitis. Lancet. 1971 Apr 3;1(7701):659–665. doi: 10.1016/s0140-6736(71)92678-x. [DOI] [PubMed] [Google Scholar]
  21. Redeker A. G., Yamahiro H. S. Controlled trial of exchange-transfusion therapy in fulminant hepatitis. Lancet. 1973 Jan 6;1(7793):3–6. doi: 10.1016/s0140-6736(73)91220-8. [DOI] [PubMed] [Google Scholar]
  22. Saito S., Sakagami K., Orita K. A new hybrid artificial liver using a combination of hepatocytes and biomatrix. ASAIO Trans. 1987 Jul-Sep;33(3):459–462. [PubMed] [Google Scholar]
  23. Silk D. B., Trewby P. N., Chase R. A., Mellon P. J., Hanid M. A., Davies M., Langley P. G., Wheeler P. G., Williams R. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet. 1977 Jul 2;2(8027):1–3. doi: 10.1016/s0140-6736(77)90001-0. [DOI] [PubMed] [Google Scholar]
  24. Smith J. W., Matsubara S., Horiuchi T., Kayashima K., Shinagawa S., Malchesky P. S., Nosé Y. Sorption-filtration therapy for chronic liver disease: in vitro testing and clinical correlation. Trans Am Soc Artif Intern Organs. 1982;28:215–219. [PubMed] [Google Scholar]
  25. Starzl T. E., Chang T., Williams R., Nose Y. Liver support/transplants and artificial organs. Trans Am Soc Artif Intern Organs. 1983;29:795–799. [PubMed] [Google Scholar]
  26. Usami M., Ohyanagi H., Nishimatsu S., Kasahara H., Shiroiwa H., Ishimoto S., Ueda T., Saitoh Y. Therapeutic plasmapheresis for liver failure after hepatectomy. ASAIO Trans. 1989 Jul-Sep;35(3):564–567. doi: 10.1097/00002480-198907000-00127. [DOI] [PubMed] [Google Scholar]
  27. Wang S. R., Renaud G., Infante J., Catala D., Infante R. Isolation of rat hepatocytes with EDTA and their metabolic functions in primary culture. In Vitro Cell Dev Biol. 1985 Sep;21(9):526–530. doi: 10.1007/BF02620846. [DOI] [PubMed] [Google Scholar]
  28. Yanagi K., Ookawa K., Mizuno S., Ohshima N. Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogel. ASAIO Trans. 1989 Jul-Sep;35(3):570–572. doi: 10.1097/00002480-198907000-00129. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES